Table 2.
Association between psoriasis and presence of atherosclerotic disease
| Model | Adjusted odds ratio of atherosclerotic disease comparing psoriasis to control patients (95 % CI) | p-value |
|---|---|---|
| Presence of psoriasis | 1.88 (1.10, 3.21) | 0.0210 |
| Presence of psoriasis + age | 3.23 (1.53, 6.80) | 0.0020 |
| Presence of psoriasis + age + gender | 3.18 (1.51, 6.69) | 0.0023 |
| Presence of psoriasis + age + gender + race | 3.18 (1.51, 6.70) | 0.0023 |
| Presence of psoriasis + age + gender + race + BMI | 2.93 (1.38, 6.23) | 0.0051 |
| Presence of psoriasis + age + gender + race + BMI + current smoker | 2.66 (1.23, 5.77) | 0.0128 |
| Presence of psoriasis + age + gender + race + BMI + current smoker + hypertension | 2.54 (1.16, 5.53) | 0.0193 |
| Presence of psoriasis + age + gender + race + BMI + current smoker + hypertension + HDL | 2.72 (1.23, 6.03) | 0.0138 |
| Presence of psoriasis + age + gender + race + BMI + current smoker +hypertension + HDL + hsCRP | 2.67 (1.20, 5.92) | 0.0161 |
Atherosclerosis defined as CAC score ≥1 (or coronary stent), or right or left CIMT >75th percentile, or the presence of carotid plaque